SG Americas Securities LLC Has $10.52 Million Stock Holdings in CME Group Inc (NASDAQ:CME)

SG Americas Securities LLC decreased its holdings in CME Group Inc (NASDAQ:CME) by 5.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 49,794 shares of the financial services provider’s stock after selling 2,696 shares during the quarter. SG Americas Securities LLC’s holdings in CME Group were worth $10,523,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in CME. Advantage Investment Management LLC raised its stake in shares of CME Group by 119.0% in the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after buying an additional 100 shares in the last quarter. Venturi Wealth Management LLC acquired a new position in shares of CME Group in the 3rd quarter valued at $36,000. Westside Investment Management Inc. acquired a new position in shares of CME Group in the 2nd quarter valued at $38,000. Bartlett & Co. LLC raised its stake in shares of CME Group by 2,471.4% in the 3rd quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock valued at $38,000 after buying an additional 173 shares in the last quarter. Finally, Private Capital Group LLC raised its stake in shares of CME Group by 44.9% in the 2nd quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after buying an additional 75 shares in the last quarter. Institutional investors own 84.80% of the company’s stock.

CME traded down $0.83 during midday trading on Friday, hitting $198.17. The company had a trading volume of 1,172,200 shares, compared to its average volume of 1,518,595. The firm’s 50-day simple moving average is $208.43 and its 200-day simple moving average is $201.58. CME Group Inc has a twelve month low of $161.05 and a twelve month high of $224.91. The company has a market capitalization of $70.53 billion, a PE ratio of 29.06, a P/E/G ratio of 3.86 and a beta of 0.18. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.05 and a current ratio of 1.04.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm earned $1.45 EPS. CME Group’s quarterly revenue was up 41.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group Inc will post 6.91 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Tuesday, December 10th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 43.99%.

A number of equities research analysts recently issued reports on CME shares. Citigroup increased their target price on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Berenberg Bank cut shares of CME Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $236.00 to $227.00 in a research report on Thursday, September 19th. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. Finally, Wells Fargo & Co increased their target price on shares of CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $203.36.

In other CME Group news, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the sale, the insider now directly owns 19,923 shares in the company, valued at approximately $4,445,418.99. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the sale, the chief financial officer now owns 30,354 shares in the company, valued at $6,605,637.48. The disclosure for this sale can be found here. Insiders have sold a total of 13,636 shares of company stock worth $3,001,008 in the last three months. 1.20% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: What is dollar cost averaging (DCA)?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.